Dr Reddys Lab, Gland Pharma to market generic injectables globally
Dr Reddys Laboratories and US-based Gland Pharma have collaborated to market and distribute a diverse portfolio of eight injectable Abbreviated […]
Dr. Reddys to acquire 8 ANDAs for $350 million – Aims to become relevant in the US
Dr. Reddys Laboratories has entered into a definitive agreement with Teva Pharmaceutical Industries Ltd and an affiliate of Allergan plc […]
